SLC18A2 and movement disorder: Building on this, our findings offer information regarding common indications, dosages, efficacy, side effects, and barriers to treatment for pediatric patients at a large pediatric movement disorders center, thus providing further guidance for providers utilizing VMAT2 inhibitors to treat pediatric movement disorders.